C-breeze 1: Efficacy and safety of ruzasvir 60 mg plus uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus (HCV) genotype (GT)1, 2, 3, 4, or 6 infection

Authors
Category Primary study
JournalHepatology
Year 2017
This article has no abstract
Epistemonikos ID: e03a20489491fd489c320fe63cb66cc3ccf607bb
First added on: Feb 08, 2025